Dr. Vincent Giampapa Receives Nobel Prize Nomination for Stem Cell Research

The creator of HealthyCell gets highest honor in Stem Cell Research.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friendRepost This
We could not be more proud of the accomplishments of Dr. Giampapa and the research team at Rutgers University on their nomination for the Nobel Prize. We hope to see them holding the award later in the year as the winner.

Montclair, NJ (PRWEB) June 09, 2014

The founding team at TrepScore™, a transparency platform that provides execution analytics for startups, recognizes and congratulates one of its earliest adopters, Dr. Vincent Giampapa and his research team at Rutgers University for their recent nomination for a 2014 Nobel Prize in the area of Stem Cell Research.

The Nobel Prize Nomination was awarded for the potential impact Dr. Giampapa’s technology may have on the global aging epidemic as well as the financial impact of future health care in all countries with aging demographics, especially in the United States.

After two years of research on the effects of young cells on old cells, Dr. Vincent Giampapa and Dr. Pranela Rameschwar have appeared to reverse the cellular aging process in humans as documented by changes in genes and proteins as well as cell function. “We could not have made this breakthrough without the funding and support of two very important people, Mr. John Malone of Liberty Media and Dr. Ed Bosarge,” said Dr. Vincent Giampapa.

Originally presented by Dr. Giampapa in Rome at the Vatican Stem For Life meeting in April 2013 and then again in Stockholm at the Swedish American Life Science Summit, his research has documented the in-vitro approach can make cellular restoration possible.

Dr Giampapa is an attending physician at Hackensack Medical Center, an Associate Clinical Professor at UMDNJ- Medical Center in New Jersey, and is also the founder of the Cell Health Institute. He has also received the EDISON Award this past year for innovation in the design of HealthyCell™, a new oral supplement based on natural plant extracts that helps keep cells healthier longer.

“We could not be more proud of the accomplishments of Dr. Giampapa and the research team at Rutgers University on their nomination for the Nobel Prize. We hope to see them holding the award later in the year as the winner,” said Eric Rice, Founder and CEO of TrepScore™.

About The HealthyCell™
CellHealth Institute is a biotech company committed to empowering people to lead healthier lives. The company focuses on combined cellular health products, such as healthycell™, along with its innovative cell health services and holistic lifestyle education in service of its mission is to help people take control of their health at the fundamental cell level. More information can be found at http://www.HealthyCell.com.

About TrepScore™
Founded by entrepreneurs and investors, TrepScore provides execution analytics for startups and private companies. Its dynamic two-way platform provides entrepreneurs a simple and easy way to manage their businesses and verified investors real-time, first-party data to make faster, more informed decisions. TrepScore is currently closing out funding and is expected to launch in late summer 2014.


Contact

  • Eric Rice
    TrepScore
    +1 8583568350
    Email
  • Anabelle Maldonado
    TrepScore Inc.